ATE498135T1 - Homogener doppelrezeptor-agglutinationstest für immunsuppressiva - Google Patents

Homogener doppelrezeptor-agglutinationstest für immunsuppressiva

Info

Publication number
ATE498135T1
ATE498135T1 AT07786032T AT07786032T ATE498135T1 AT E498135 T1 ATE498135 T1 AT E498135T1 AT 07786032 T AT07786032 T AT 07786032T AT 07786032 T AT07786032 T AT 07786032T AT E498135 T1 ATE498135 T1 AT E498135T1
Authority
AT
Austria
Prior art keywords
immunosupressives
agglutination test
receptor
homogeneous
dual receptor
Prior art date
Application number
AT07786032T
Other languages
English (en)
Inventor
Gerald Sigler
Mitali Ghoshal
Shaker Rashid
Yifei Wu
Allan Dorn
Jane Tsai
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE498135T1 publication Critical patent/ATE498135T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9493—Immunosupressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54346—Nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nanotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT07786032T 2006-07-13 2007-07-12 Homogener doppelrezeptor-agglutinationstest für immunsuppressiva ATE498135T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80724506P 2006-07-13 2006-07-13
US11/772,886 US20080081379A1 (en) 2006-07-13 2007-07-03 Homogeneous double receptor agglutination assay for immunosuppressant drugs
PCT/EP2007/006200 WO2008006588A1 (en) 2006-07-13 2007-07-12 Homogeneous double receptor agglutination assay for immunosuppressant drugs

Publications (1)

Publication Number Publication Date
ATE498135T1 true ATE498135T1 (de) 2011-02-15

Family

ID=38535540

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07786032T ATE498135T1 (de) 2006-07-13 2007-07-12 Homogener doppelrezeptor-agglutinationstest für immunsuppressiva

Country Status (7)

Country Link
US (1) US20080081379A1 (de)
EP (1) EP2041580B1 (de)
JP (1) JP2009543084A (de)
AT (1) ATE498135T1 (de)
CA (1) CA2657588A1 (de)
DE (1) DE602007012439D1 (de)
WO (1) WO2008006588A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5364096B2 (ja) * 2007-08-17 2013-12-11 コリア アドバンスド インスティチュート オブ サイエンス アンド テクノロジィ 物質の相互作用検出方法
SG190572A1 (en) 2008-04-29 2013-06-28 Abbott Lab Dual variable domain immunoglobulins and uses thereof
CA2726087A1 (en) 2008-06-03 2009-12-10 Tariq Ghayur Dual variable domain immunoglobulins and uses thereof
WO2010123993A1 (en) * 2009-04-21 2010-10-28 Tuan Vo-Dinh Non-invasive energy upconversion methods and systems for in-situ photobiomodulation
UY33492A (es) 2010-07-09 2012-01-31 Abbott Lab Inmunoglobulinas con dominio variable dual y usos de las mismas
EP3252072A3 (de) 2010-08-03 2018-03-14 AbbVie Inc. Immunglobuline mit zweifacher variabler domäne und verwendungen davon
US8563298B2 (en) 2010-10-22 2013-10-22 T2 Biosystems, Inc. NMR systems and methods for the rapid detection of analytes
CA2815085C (en) 2010-10-22 2022-06-21 T2 Biosystems, Inc. Nmr systems and methods for the rapid detection of analytes
US8409807B2 (en) 2010-10-22 2013-04-02 T2 Biosystems, Inc. NMR systems and methods for the rapid detection of analytes
EP2839038B1 (de) 2012-04-20 2019-01-16 T2 Biosystems, Inc. Zusammensetzungen und verfahren für den nachweis einer candida-spezies
CN107110853A (zh) 2015-01-09 2017-08-29 阿通诺米斯公司 确定TNFα抑制药及其相应抗药抗体的量的通用测定法
JP7523776B2 (ja) 2016-01-21 2024-07-29 ティー２ バイオシステムズ，インコーポレーテッド 細菌を迅速に検出するｎｍｒ法及びシステム
WO2018007327A1 (en) * 2016-07-08 2018-01-11 Atonomics A/S A universal assay for determining the quantity of therapeutic monoclonal antibodies and their corresponding anti-drug-antibodies in samples
CN110191955B (zh) 2016-12-13 2024-05-31 西雅图儿童医院（Dba西雅图儿童研究所） 在体外和体内对工程化的细胞中表达的化学物质诱导的信号传导复合物进行外源性药物激活的方法
WO2019210057A1 (en) 2018-04-27 2019-10-31 Seattle Children's Hospital (dba Seattle Children's Research Institute) Rapamycin resistant cells
US20220229049A1 (en) * 2019-06-28 2022-07-21 Siemens Healthcare Diagnostics Inc. Reagents for sandwich immunoassays using particle enhanced agglutination detection and methods of production and use thereof
JP2024113375A (ja) * 2023-02-09 2024-08-22 日本光電工業株式会社 試料中の測定対象物を検出する免疫測定方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH032565A (ja) * 1989-05-30 1991-01-08 Olympus Optical Co Ltd 免疫学的分析方法
DE69133095T2 (de) * 1990-11-20 2003-03-27 Dade Behring Marburg Gmbh Cyclosporin-Immunoassay
GB9307491D0 (en) * 1993-04-08 1993-06-02 Sandoz Ltd Organic compounds
US5874239A (en) * 1993-07-30 1999-02-23 Affymax Technologies N.V. Biotinylation of proteins
US6187547B1 (en) 1993-09-08 2001-02-13 Novartis Ag Assay kit
JP3292766B2 (ja) * 1993-09-20 2002-06-17 積水化学工業株式会社 糖化蛋白の測定方法
MX9603838A (es) 1994-03-10 1997-03-29 Fujisawa Pharmaceutical Co Metodo para ensayar inmunosupresores.
US6150137A (en) * 1994-05-27 2000-11-21 Ariad Pharmaceuticals, Inc. Immunosuppressant target proteins
US5922551A (en) * 1997-03-20 1999-07-13 Accumetrics, Inc. Agglutrimetric platelet binding assays in blood
US6709873B1 (en) * 1997-04-09 2004-03-23 Isodiagnostika Inc. Method for production of antibodies to specific sites of rapamycin
JP3513075B2 (ja) * 2000-04-05 2004-03-31 デンカ生研株式会社 免疫測定法及びそのための試薬
EP1239285A1 (de) 2001-03-07 2002-09-11 Roche Diagnostics GmbH Verbesserte Methode für ein homogenes Immunotestverfahren
US20030003503A1 (en) * 2001-06-29 2003-01-02 Tsai Tenlin S. Enhancing sensitivity and equimolar detection through modifications of the reaction environment
EP1699415A4 (de) 2003-12-29 2008-01-09 Univ Ramot Assay zum nachweis von rapamycin und rapamycin-analoga
WO2005088307A1 (en) 2004-03-10 2005-09-22 Seradyn Inc. Immunoassays for everolimus
US8021849B2 (en) * 2004-11-05 2011-09-20 Siemens Healthcare Diagnostics Inc. Methods and kits for the determination of sirolimus in a sample
EP2180323B1 (de) * 2005-04-06 2012-02-01 Abbott Laboratories Verfahren zur Messung immunsuppressiver Tacrolimus-, Sirolimus- und Cyclosporin-A-Komplexe in einer Blutprobe
US7611908B2 (en) * 2005-05-02 2009-11-03 Bioscale, Inc. Method and apparatus for therapeutic drug monitoring using an acoustic device
US7642059B2 (en) * 2005-09-07 2010-01-05 Roche Diagnostics Operations, Inc. Single receptor assays for immunosuppressive drugs

Also Published As

Publication number Publication date
DE602007012439D1 (de) 2011-03-24
CA2657588A1 (en) 2008-01-17
EP2041580A1 (de) 2009-04-01
WO2008006588A1 (en) 2008-01-17
JP2009543084A (ja) 2009-12-03
EP2041580B1 (de) 2011-02-09
US20080081379A1 (en) 2008-04-03

Similar Documents

Publication Publication Date Title
ATE498135T1 (de) Homogener doppelrezeptor-agglutinationstest für immunsuppressiva
BR112012009846A2 (pt) ensaios para detecção de anticorpos específicos para anticorpos anti-ige terapêuticos e seu uso em anafilaxia
EP2438442A4 (de) Verfahren und tests zur messung von p95 und/oder p95 in einer probe und für p95 spezifische antikörper
BRPI1007867B8 (pt) anticorpo recombinante ou fragmento de ligação ao antígeno do mesmo, composição farmacêutica e kit compreendendo o referido anticorpo, métodos de detecção de antígeno de troponina i em uma amostra de teste e métodos in vitro de diagnóstico de síndrome coronariana aguda ou infarto do miocárdio em um paciente
BRPI0915619A2 (pt) métodos para determinar uma probabilidade de que um sujeito tenha contribuído com material genético para amostra de teste de material genético, para caracterizar amostra de teste de material genético e para determinar se uma pessoa de interesse contribuiu com material genético para uma amostra de teste de material genético, kit para análise de amostra de teste de material genético e sistema para determinar se um sujeito contribuiu com material genético para uma amostra
WO2010046443A3 (en) Methods for detection and diagnosis of a bone or cartilage disorder
JP2011524537A5 (de)
WO2009079156A3 (en) Detection devices and methods
ATE485514T1 (de) Immunoassay mit mehreren analyten
BRPI0923199B8 (pt) método para determinar a presença de anticorpos de fixação de complemento
BR112012031071A2 (pt) 8-proteínas de ligação à il-1
BRPI0720707A2 (pt) Sistema de teste para uso com um tampão para testar a presença de moléculas alvo de um ou mais tipos de alvo em uma amostra de teste biológico; sistema de teste para testar a presença de moléculas alvo de um ou mais tipos de alvo em uma amostra de teste biológico; e método de focalização de moléculas para facilitar um teste da presença de moléculas alvo de um ou mais tipos de alvo de uma amostra de teste biológico.
ATE547705T1 (de) Kohlenhydratnachweissensor
BR112016010106A2 (pt) ensaios para igfbp7 com melhor desempenho em amostras biológicas
ATE412179T1 (de) Nachweis von arzneistoffen der methamphetamingruppe
BR112012019475A8 (pt) uso de um anticorpo monoclonal anti-cd44, anticorpo monoclonal anti-cd44, anticorpo anti-cd44 humanizado e kit para a detecção da presença de hnscc em uma amostra
BR112012029769A2 (pt) processo para a detecção eletroquímica de reações de ligação
ATE514081T1 (de) T-zellen-testverfahren
TR201909273T4 (tr) Bir pegile analit spesifik bağlanma ajanının kullanıldığı partikül bazlı immünolojik test.
BRPI0818529A2 (pt) uso do ensaio sorológico da citocina estimuladora de linfócito b (blys) para um teste prognóstico e de monitoramento de reações à transfusões imune-relacionadas
JP2010526995A5 (de)
WO2013169931A3 (en) Assays and cell-based tests using a receptor na/k-atpase/src complex and uses thereof
JP2009507234A5 (de)
EP2444812A3 (de) Verbesserte Immunoassayverfahren
TR201820490T4 (tr) Çözünür fibroblast büyüme faktörü reseptörleri için hassas multipleks immunoeseyleri.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2041580

Country of ref document: EP